Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 1

Status

Recruiting 3Terminated 2

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Other solid neoplasm 5

Conditions

Advanced Solid Tumors 35Advanced Solid Tumor 22Solid Tumors 17Mesothelioma 16Solid Tumor 12Mesothelioma, Malignant 11Hematopoietic and Lymphatic System Neoplasm 10Ovarian Neoplasms 7Solid Tumor, Adult 5Pancreatic Neoplasms 5Malignant Solid Neoplasm 5Solid Tumours 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Advanced Solid Tumour 4Stomach Neoplasms 3Small Cell Lung Carcinoma 3Sarcoma 3Kidney Neoplasms 3Advanced or Metastatic Solid Tumors 3Advanced Malignant Solid Tumors 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Thymus Neoplasms 2Solid Tumor Malignancies 2Solid Tumor Cancer 2Retinoblastoma 2Rectal Neoplasms 2Neoplasms 2Metastatic Solid Tumors 2

Interventions

pembrolizumab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Solid Tumor, Adult × Other solid neoplasm × 30 days × Clear all
NCT06977737 2026-05-22

ATTEST

Accession Therapeutics Limited

Phase 1/2 Recruiting
72 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT06265688 2026-05-19

First In Human Study of CX-2051 in Advanced Solid Tumors

CytomX Therapeutics

Phase 1 Recruiting
160 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT06462794 2026-05-15

First In Human Study of CX-801 in Advanced Solid Tumors

CytomX Therapeutics

Phase 1 Recruiting
121 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT05582850 2026-05-12

EPRAD

Domain Therapeutics SA

Phase 1 Terminated
29 enrolled 12 charts
Other solid neoplasm

Solid Tumor, Adult

NCT07159828 2026-05-06

A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

Instil Bio

Phase 1 Terminated
3 enrolled
Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon âš¡